Pharmaceutical

Interactive Strength Inc. (Nasdaq:TRNR) Investment Drives Sportstech’s 24% YoY Revenue Growth for the Third Quarter of 2025

Sportstech Revenue Growth Accelerated from 18% YoY in Second Quarter, and is Expected to Surpass 30% YoY in Fourth QuarterCurrent…

2 months ago

AllStar Health Brands Updates on Exciting Developments and Expansions

MIAMI, FL / ACCESS Newswire / November 5, 2025 / AllStar Health Brands (ALST:OTCIQ) is pleased to share several significant…

2 months ago

Bausch Health’s OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease

Expansion improves access to treatment options within periodontal care and helps strengthen partnerships with dental professionals within these populations. LAVAL,…

2 months ago

TailorMed Showcases Innovative Patient-Facing Solution at Becker’s Fall Chief Pharmacy Officer Summit

TailorMed Connect Gives Patients Direct Access to Critical Support While Scaling Health Systems' Impact NEW YORK, NY / ACCESS Newswire…

2 months ago

Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025

Company to host conference call to discuss financial results and provide a corporate update on November 12, 2025 at 4:30…

2 months ago

Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL™ in Parkinson’s Disease

Jupiter, Florida, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ:JUNS), a clinical-stage pharmaceutical company developing JOTROL™, a patented…

2 months ago

MaxCyte Reports Preliminary Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance

MaxCyte will now host its earnings conference call on November 12, 2025 Management will present at the Stifel Healthcare Conference…

2 months ago

Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025

Company to hold a conference call at 8:00 a.m. ETDURHAM, N.C., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc.…

2 months ago

CelLBxHealth PLC Presents Proof-of-Concept Study

CelLBxHealth presents proof-of-concept study using Roche Tissue Diagnostics' workflow at world-leading drug development conferenceParsortix platform shown to be compatible with…

2 months ago